Edition:
United Kingdom

Lennox International Inc (LII.N)

LII.N on New York Stock Exchange

216.48USD
19 Jan 2018
Change (% chg)

$2.49 (+1.16%)
Prev Close
$213.99
Open
$214.78
Day's High
$216.79
Day's Low
$214.05
Volume
50,094
Avg. Vol
87,203
52-wk High
$216.79
52-wk Low
$150.47

Chart for

About

Lennox International Inc. is a provider of climate control solutions. The Company designs, manufactures and markets a range of products for the heating, ventilation, air conditioning and refrigeration (HVACR) markets. It operates through three segments: Residential Heating & Cooling; Commercial Heating & Cooling, and Refrigerati... (more)

Overall

Beta: 1.19
Market Cap(Mil.): $7,774.93
Shares Outstanding(Mil.): 42.18
Dividend: 0.51
Yield (%): 1.11

Financials

  Industry Sector
P/E (TTM): -- 27.95 16.58
EPS (TTM): -- -- --
ROI: -- 10.64 10.60
ROE: -- 12.80 14.19

BRIEF-Ovid Therapeutics Announces TAK-935/OV935 Granted Orphan Drug Designation By U.S. FDA For Treatment Of Lennox-Gastaut Syndrome

* OVID THERAPEUTICS ANNOUNCES TAK-935/OV935 GRANTED ORPHAN DRUG DESIGNATION BY U.S. FDA FOR TREATMENT OF LENNOX-GASTAUT SYNDROME

20 Dec 2017

BRIEF-Lennox International Sees Fy18 Revenue Up 3 To 7 Percent

* REAFFIRMS FY 2017 ADJUSTED EARNINGS PER SHARE VIEW $7.75 TO $8.05 FROM CONTINUING OPERATIONS

13 Dec 2017

BRIEF-Lennox International says Lpac, co entered into amendment to amended, restated receivables purchase agreement initially dated Nov 18, 2011

* Lennox International - ‍as of Nov 13, Lennox, Lpac, co entered into amendment to amended, restated receivables purchase agreement initially dated nov 18, 2011

16 Nov 2017

Earnings vs. Estimates